About EligoChem

EligoChem has developed a proprietary and patentable technology that facilitates the design of highly water-soluble drugs that are absorbed well by the human body. One in fifteen known drug compounds have this combination of properties, but they are present in only one in ten thousand compounds in current pharma screening collections. This technology is particularly suited to antibiotic drug discovery.

Company Highlights
Year Founded

2012

icon-altEmployees

2

Location (HQ)

GBR

Since Last Funding

7 years

Monthly Website Visitors

1.3K

icon-altTotal Investment Amt

$4.8M

Last Funding Round

Grant

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology

Pharmaceutical

Pharmaceutical Manufacturing

App Discovery